Roc Partners hits $120m third close on fourth Asia fund
Australia-based private equity firm Roc Partners has reached a third close of $120.1 million for its fourth Asia Pacific fund-of-funds.
The vehicle achieved a first close of $36 million in December 2018 and a second close of $60 million one year later. The original target was $100 million, and the hard cap has been set at $150 million....
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.